Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Am J Prev Med. 2022 Nov 10;64(3):361–367. doi: 10.1016/j.amepre.2022.09.019

Effects of Cannabis Legalization on Adolescent Cannabis Use Across 3 Studies

Jennifer A Bailey 1, Stacey S Tiberio 2, David CR Kerr 2, Marina Epstein 1, Kimberly L Henry 3, Deborah M Capaldi 2
PMCID: PMC9975019  NIHMSID: NIHMS1863874  PMID: 36372654

Abstract

Introduction:

Canada, Uruguay, and 18 states in the U.S. have legalized use of nonmedical (recreational) cannabis for adults, yet the impact of legalization on adolescent cannabis use remains unclear. This study examined whether cannabis legalization for adults predicted changes in the probability of cannabis use among adolescents ages 13–18 years.

Methods:

Data were drawn from 3 longitudinal studies of youth (spanning 1999–2020) centered in 3 U.S. states: Oregon, New York, and Washington, respectively. During this time, Oregon (2015) and Washington (2012) passed cannabis legalization; New York did not. In each study, youth averaged 15 years of age (total N=940; 49%–56% female; 11%–81% Black/African American and/or Latinx). Multilevel modeling (in 2021) of repeated measures tested whether legalization predicted within- or between-person change in past year cannabis use or use frequency over time.

Results:

Change in legalization status across adolescence was not significantly related to within-person change in the probability or frequency of self-reported past year cannabis use. At the between-person level, youth who spent more of their adolescence under legalization were no more or less likely to have used cannabis at age 15 years than adolescents who spent little or no time under legalization.

Conclusions:

The current study addresses several limitations of repeated cross-sectional studies of the impact of cannabis legalization on adolescent cannabis use. Findings are not consistent with changes in the prevalence or frequency of adolescent cannabis use following legalization. Ongoing surveillance and analyses of subpopulations are recommended.

INTRODUCTION

Despite its importance as a policy shift and widespread adoption by states, research on the impact of nonmedical cannabis legalization for adults (“legalization” for brevity) is in its early stages. Early onset, frequent, heavy, or prolonged cannabis use during adolescence is associated with difficulties with academic performance and attainment, social relationships, depression, suicidal thoughts and behaviors, substance use disorder, and poorer adult functioning.14 Thus, possible increases in adolescent cannabis use following legalization of adult cannabis use are of concern for public health. To date, little is known about changes in adolescent cannabis use associated with legalization.5,6 A clear understanding of whether adolescent cannabis use may increase following legalization is critical to inform policy and prevention.

Although use of nonmedical cannabis remains illegal for individuals under age 21 years in all states, legalization of adult use may lead to higher rates of, more frequent, or heavier cannabis use among adolescents via increased availability, removal of legal penalties, increasing potency, decreased perceptions of harm, and increased perceptions of acceptability.710 Factors like removal of penalties and increasing acceptability may result, respectively, in immediate or delayed changes in use - or both. Early evidence suggests that adolescent cannabis use is largely unchanged following legalization. In the U.S., Youth Risk Behavior Surveillance System (YRBSS) data from 1999–2017 showed no change in the likelihood of cannabis use among youth ages 14–18 years (grades 9–12) and decreases in cannabis use frequency among users following legalization.11 Data from the National Survey on Drug Use and Health showed no significant change from 2008 to 2016 in past-month cannabis use or heavy use among youth. Early data from Canada also suggest that youth cannabis use is largely holding steady following nationwide legalization in 2018.12,13

Other studies used repeated cross-sectional data from large, state-specific datasets to test for post-legalization changes in cannabis use. For example, statewide data from the California Healthy Kids Survey spanning 2010–2018 showed increases in both past-month and lifetime cannabis use among 7th-, 9th-, and 11th-grade students.14 Conversely, a study using 2010–2016 data from the Washington Healthy Youth Survey found no change in the prevalence of past-month cannabis use among 12th graders following legalization, and significant decreases among 8th and 10th graders.15

Large, repeated cross-sectional studies afford strong tests of population-level associations, but preclude parsing of within- versus between-person change and tests of whether population-level changes are being “driven by individuals whose cannabis use actually changed.”17 Repeated cross-sectional data may confound changes in use attributable to legalization with nationwide trends in cannabis use. Conversely, longitudinal studies address all of these limitations. Longitudinal studies including multiple birth cohorts are particularly well-suited to parse the influences of age and legalization on cannabis use because they enable the separation of change due to individual development (age) from change due to history (birth cohort and legalization). Longitudinal datasets allowing examination of both within- and between-person effects of legalization are especially rare.6

To the authors’ knowledge, there are 3 published longitudinal studies of adolescent cannabis use including assessments before and after legalization. Short-term longitudinal data from Oregon eighth and ninth graders showed that adolescents who were already using cannabis used more frequently after legalization, but legalization did not predict increased prevalence of use.18 Canadian data from the longitudinal arm of the COMPASS project showed a steeper rise in cannabis use from ages 16 to 17 years among males after compared to before legalization,12 but overall trends in cannabis use over time did not differ following legalization. Findings from the Seattle Social Development Project – The Intergenerational Project (SSDP-TIP) suggest that the probability of any past-year cannabis use among youth ages 10–20 years in Washington State was higher after legalization.19

The Three Generation Research Consortium study brings together 3 prospective, intergenerational studies: the Three Generation Study (3GS; 2005–2020), the Rochester InterGenerational Study (RIGS; 1999–2019), and SSDP-TIP (2002–2018; henceforth TIP for brevity). These studies are all broadly focused on understanding the intergenerational transmission of substance use and risk behavior. 3GS (Oregon) and TIP (Washington) are centered in 2 of the earliest states to legalize nonmedical cannabis use, and included assessments of youth from multiple birth cohorts both before and after cannabis legalization. RIGS data were collected well before New York State legalized cannabis in 2021, and provide “nonlegal” comparison data.

This study aimed to extend the earlier TIP study19 by integrating data from 3 longitudinal datasets to test whether legalization predicted changes in past-year cannabis use or use frequency among youth at both the within- and between-person levels. The analytic approach involved comparison of cannabis use among: (1) adolescents in Oregon and Washington surveyed both before and after legalization (within-person effects) and (2) individuals of the same ages who had versus had not lived in areas or at times where/when recreational marijuana use was legal for adults (between-person effects). The New York sample comprised the majority of this latter group, but some 3GS and TIP participants aged through adolescence before legalization or left Oregon and Washington.

METHODS

Study Sample

Participants in 3GS were the children of men in the longitudinal Oregon Youth Study (OYS). Participants’ fathers were originally recruited to OYS as boys in 1983–1985 from fourth grade classes of schools in neighborhoods of a midsized Oregon city with higher than city-average rates of juvenile arrests. Beginning in 2005, OYS men who became fathers were invited to participate in 3GS with their first 2 biological children by each mother (i.e., a participant with 2 children each with 2 women might have 4 children in the study); 93% of eligible families were recruited. The 3GS is ongoing. The present analyses included observations from 2005–2020 from 186 3GS participants (44.4% male; 10.6% Black/African American and/or Latinx) assessed at least once from ages 13 to 18 years. They were born on average in 1998 (range: 1990–2005). On average, 3GS youth were 15.3 years old, and 31.1% of assessments occurred in a time and place when legalization was in effect. Retention from wave to wave has averaged 82%.

Participants in RIGS were children of youth recruited to the longitudinal Rochester Youth Development Study (RYDS), a sample representative of seventh/eighth graders in Rochester, New York, public schools in 1988, with oversampling of boys and children residing in areas of the city with a high resident arrest rate. Beginning in 1999, firstborn children of RYDS participants were recruited into RIGS. In subsequent years, any new firstborns were recruited once they reached age 2 years. Children were assessed annually to age 18 years (in 2019). The present analyses included 471 RIGS children (49.4% male; 80.6% Black/African American and/or Latinx) assessed at least once from 1999–2019 at ages 13–18 years [mean birth year=1995 (range: 1986–2005)]. On average, RIGS youth were 15.4 years old, and 0.2% of observations occurred when and where legalization was in effect. Retention through the end of the study was 86%.

Participants in TIP were children of participants in the longitudinal Seattle Social Development Project (SSDP) who were recruited in 1985 (during a period of busing to reduce racial segregation) at age 10 years from public elementary schools that served, but were not necessarily located in, higher-crime neighborhoods in Seattle, Washington. Starting in 2002, SSDP participants who had become parents were recruited (family rate of 82%) to TIP along with the oldest biological child with whom they had regular contact. The children were assessed in 10 subsequent waves, the latest in 2018. The present analyses included 283 youth (51.4% male; 32.4% Black/African American and/or Latinx) assessed at least once from 2002–2018 across ages 13 to 18 years [mean birth year=1997 (range: 1989–2004)]. On average, TIP youth were 15.5 years old, and 35.4% of the assessments occurred in a state and at a time when legalization was in effect. Retention from wave to wave averaged 92%.

Procedures and measures for the 3 studies were approved by IRBs at the Oregon Social Learning Center (3GS), the State University of New York at Albany (RIGS), and the University of Washington (TIP). Table 1 shows the numbers of observations from each study that were available at each adolescent age. Adolescents were assessed annually from ages 13–18 in RIGS and TIP, and biannually in 3GS at ages 13–14, 15–16, and 17–18 years. Age at each assessment was rounded down to the nearest year for analysis. Samples sizes are lower at ages 17 and 18 years because some offspring had not yet reached those ages.

Table 1.

Sample Size, Number of Observations, and Prevalence of Cannabis Use and Legalization by Study

Age (years)
Study 13 14 15 16 17 18 Total
Observations (k)
 TIP (n=283) 124 105 114 101 107 89 640
 RIGS (n=471) 427 442 441 427 407 392 2,536
 3GS (n=186) 81 97 67 102 36 91 474
 Total (N=940) 632 644 622 630 550 572 3,650
Prevalence past-year cannabis use
 TIP 0% 7% 10% 16% 27% 38% 15%
 RIGS 3% 5% 8% 15% 20% 29% 13%
 3GS 10% 8% 34% 31% 33% 40% 25%
 Total 3% 6% 11% 17% 22% 32% 15%
Frequency past-year cannabis use
 TIP
  No use 100% 93% 90% 84% 73% 62% 85%
  1 −20 times 0% 7% 8% 13% 18% 56% 11%
  ≥21 times 0% 0% 2% 3% 9% 12% 4%
 RIGS
  No use 97% 95% 92% 85% 80% 71% 87%
  1 −20 times 2% 4% 7% 11% 14% 20% 10%
  ≥21 times <1% 1% 2% 4% 6% 9% 3%
 3GS
  No use 90% 92% 66% 69% 67% 60% 75%
  1–20 times 6% 6% 24% 23% 25% 20% 16%
  ≥21 times 4% 2% 10% 9% 8% 20% 9%
Mean years in legal state (range 0–3)
 TIP 0.80 0.91 0.97 1.06 0.95 0.88 0.93
 RIGS 0.01 0.01 0.01 0.01 0.01 0.00 0.01
 3GS 0.81 0.54 0.76 0.64 0.44 0.63 0.65
 Total 0.25 0.23 0.26 0.28 0.22 0.24 0.26

Note: Percentages may sum to more than 100 due to rounding.

TIP, Seattle Social Development Project – The Intergenerational Project; RIGS, Rochester InterGenerational Study; 3GS, Three Generation Study.

Measures

Adolescents self-reported their frequency of cannabis use in the last year at each biannual assessment for 3GS and each annual assessment for TIP or since their last (annual) interview for RIGS. Thus, this outcome was easily harmonized across studies. Cannabis use before age 13 years was too rare to model accurately, and was excluded. Two outcome measures were created: any past year use (1 yes, 0 no) and frequency of use (0 no use, 1 1–20 occasions, 2 21+ occasions). Frequency of use was split at 20 versus 21+ occasions because reports of using >20 times per year were rare in these community samples of adolescents.

Most participants affected by legalization were in Washington State or Oregon, where the policy went into effect in December 2012 and July 2015, respectively; for the small numbers of assessments occurring in other legalized states (e.g., California), the enactment dates in those locations were used. At level 1, legalization was treated as time-varying and coded as (1) in effect, or (0) not in effect at the time and place of each adolescent assessment, based on the dates when possession and use by adults became legal. The level-1 legalization variable was person-mean centered to denote within-person effects of legalization on cannabis use across adolescence. RIGS observations did not contribute to the time-variant, or within-person, legalization effect because recreational cannabis use was illegal for all but 1 participant (at 3 assessments).

At level 2, a time-invariant, or between-person, legalization predictor was coded as the number of assessments occurring at a time and place with legalization and then grand-mean centered. Thus, the level-2 legalization effect denotes the extent to which youth were more likely to use cannabis if they were exposed to legalization across more versus fewer years (including none at all).

Race/ethnicity (Black/African American and/or Latinx=1 or not=0), sex (male=1 or female=0), birth cohort year (grand-mean centered at 1996), and average age (grand-mean centered at age 15 years) were included in all models. All models also controlled for study membership using 2 dummy variables (referent: TIP).

Statistical Analysis

Data were pooled across studies (N=940 adolescents; 3,650 person-by-time assessments) and arrayed by age. Multilevel modeling (in 2021) was used to test effects of legalization on the likelihood and frequency of cannabis use at the within- (level-1, age) and between-subjects (level-2, adolescents) levels across ages 13–18 years. Models were estimated using Robust Maximum Likelihood estimation with a logit link in Mplus (version 8.4) with cannabis use and use frequency designated as categorical outcomes and modeling linear and quadratic changes in cannabis use across adolescence. Accounting for overall age trends and cohort effects was important, because later-born offspring may have been at lower contextual risk for cannabis use,20 but were exposed to legalization across more of their development. The TYPE=COMPLEX option was used to account for family clustering in the 3GS sample. Missing data were handled using Full Information Maximum Likelihood estimation. A grand-mean-only model was estimated first to obtain an estimate of the intraclass correlation (ICC) and test for significant linear and quadratic changes in the probability of cannabis use over time. Next, the level-2 control variables were included. Finally, legalization was included as both a level-1 and level-2 predictor of adolescent cannabis use. Significance tests were 2-sided. Final model equations were:

Level 1:Outcomeij=β0j+β1j(Ageij)+β2j(Age2ij)+β3j(Legalizationtime varyingij)
Level 2:β0j=γ00+γ01(Mean agej)+γ02(Birth yearj)+γ03(Black/Latinxj)+γ04(Malej)+γ05(In 3GSj)+γ06(In RIGSj)+γ07(Legalizationmeanj)+u0j
β1j=γ10
β2j=γ20
β3j=γ30

RESULTS

Table 1 shows sample sizes and prevalence/frequency of cannabis use, legalization, and years lived in a legal state by age and study. Cannabis use prevalences across ages are comparable to state-specific data from the 2018–2019 National Survey on Drug Use and Health.21

There was a high degree of within-person dependence in past year cannabis use across observations (ICC=0.532 in the grand-mean-only model). Tables 2 and 3 show results for the dichotomous past year cannabis use and cannabis use frequency outcomes, respectively. The quadratic model fit best for both outcomes, given significant nonlinear trends. Identifying as Black/African American and/or Latinx and/or participating in TIP versus 3GS predicted both a lower probability and frequency of past year cannabis use; being born in more recent years predicted a lower probability, but not frequency, of use. There was no effect of sex or average age of participation on the probability or frequency of cannabis use. The level-1 (within-person) effect of change in legalization status across adolescence was not significantly related to within-person change in the probability or frequency of cannabis use. At level 2, youth who spent more years under legalization were no more or less likely to have used cannabis and did not use either more or less frequently at age 15 years than adolescents who spent little or no time under legalization. Sensitivity analyses using (1) cannabis use frequency (0–21+) as a count variable in a Poisson model, (2) “ever lived under legalization” (yes/no) at level 2 (3) proportion of available waves lived under legalization at level 2, (4) legalization at level 1 only, and (5) with and without group- and grand mean centering of legalization variables yielded the same null finding.

Table 2.

Between- and Within-Person Effects of Legalization on Past-Year Cannabis Use (Yes/No) Across Ages 13–18 Years

Parameter Unstandardized estimate (SE) Standardized estimate bStdY (SE) p-value
Within-person effect
 Age 0.953 (0.099) 0.403 (0.028) <0.001
 Age2 −0.075 (0.035) −0.032 (0.014) 0.024
 Legalization (time-varying) 0.358 (0.493) 0.151 (0.210) 0.470
Between-person effect
 Mean age 0.099 (0.185) 0.037 (0.070) 0.593
 Birth year −0.101 (0.044) −0.038 (0.016) 0.019
 Black/Afr. Am./Latinx −0.676 (0.322) −0.255 (0.118) 0.031
 Male 0.078 (0.243) 0.030 (0.092) 0.748
 Study: 3GS vs TIP 1.229 (0.376) 0.464 (0.138) 0.001
 Study: RIGS vs TIP −0.197 (0.360) −0.074 (0.137) 0.586
 Legalization (years exposed) 0.150 (0.191) 0.057 (0.072) 0.430

Notes: Boldface indicates statistical significance (p<0.05). P-values presented are for standardized estimates. bStdY = b/SD(Y) and bStdY estimates denote the change in the predicted log-odds in standardized units for a 1 unit change in the predictor.

Age2, age squared; Afr. Am., African American; TIP, Seattle Social Development Project – The Intergenerational Project; RIGS, Rochester InterGenerational Study; 3GS, Three Generation Study.

Table 3.

Between- and Within-Person Effects of Legalization on Past-Year Cannabis Use Frequency Across Ages 13–18 Years

Parameter Unstandardized estimate (SE) Standardized estimate bStdY (SE) p-value
Within-person effect
 Age 0.969 (0.100) 0.406 (0.028) <0.001
 Age2 −0.065 (0.032) −0.027 (0.013) 0.036
 Legalization (time-varying) 0.306 (0.472) 0.128 (0.199) 0.519
Between-person effect
 Mean age 0.136 (0.193) 0.048 (.068) 0.478
 Birth year −0.085 (0.045) −0.030 (.016) 0.059
 Black/Afr. Am./Latinx −0.691 (0.344) −0.245 (.120) 0.040
 Male 0.116 (0.254) 0.041 (.091) 0.650
 Study: 3GS vs TIP 1.341 (0.387) 0.476 (.133) <0.001
 Study: RIGS vs TIP −0.104 (0.383) −0.037 (0.136) 0.786
 Legalization (years exposed) 0.181 (0.203) 0.064 (0.071) 0.369

Note: Boldface indicates statistical significance (p<0.05). P-values presented are for standardized estimates. bStdY = b/SD(Y) and bStdY estimates denote the change in the predicted log-odds in standardized units for a 1 unit change in the predictor.

Age2, age squared; Afr. Am., African American; TIP, Seattle Social Development Project – The Intergenerational Project; RIGS, Rochester InterGenerational Study; 3GS, Three Generation Study.

DISCUSSION

This study integrated longitudinal data from 3 studies of youth centered in 3 states—2 that adopted cannabis legalization early on and 1 that did not—to examine whether legalization predicted changes in the probability or frequency of past-year cannabis use among adolescents. A novel contribution of the present study was the attempt to disentangle within-person versus between-person changes in cannabis use following legalization. Thus, it was assessed whether legalization coincided with a higher or lower likelihood or frequency of past-year cannabis use within the same adolescents across time, and between-person differences in the probability and frequency of cannabis use for youth who spent more years in states with legalization. Results did not support an association between legalization and either within- or between-person change in cannabis use from ages 13–18 years.

Taken together with prior studies, these findings add weight to the conclusion that adolescent cannabis use is holding steady in the wake of legalization, at least in the years relatively proximate to the policy change. The current analyses expand on prior findings by specifically parsing variance in adolescent cannabis use due to age, sex, birth cohort (i.e., population-level trends in use), and legalization.

Despite the current findings, continued monitoring of potential changes in adolescent cannabis use following legalization is warranted. Legalization may have different effects in different states, depending on the specific policies in place or levels of use and pro-use norms prior to passage of legalization. Both Oregon and Washington had relatively high rates of adolescent cannabis use22 and well-established medical cannabis markets prior to legalization. Legalization may have less of an impact (or no impact) in these states due to existing high rates of use. Alternatively, differences in policy implementation, such as the location and number of outlets and allowance of home-grows may have differing implications for adolescent cannabis use.23 Additionally, the effects of legalization on adolescent cannabis use may take more years to emerge or be detected24 than were covered by the present study. For example, Bae and Kerr25 found both initial and compounding increases over time in the effects of legalization on college students’ cannabis use in early, middle, and later-adopting states. Notably, following the repeal of alcohol prohibition in the U.S. in 1933, population levels of drinking did not reach pre-prohibition levels for 40 years.24

Limitations

Several limitations should be considered when interpreting the current findings. The included samples were not state-representative; although the focal youth themselves lived in a broad range of neighborhood contexts, their parents were participants in studies that oversampled youth who lived in relatively higher crime neighborhoods in their respective cities in the 1980s. Higher crime and lower SES communities are important to study because they often experience disproportionate legal consequences from substance use and are under resourced with regard to treatment. Youth in Oregon and Washington were pooled for testing effects of legalization, despite policy differences in these states. Findings may not generalize to either state or to other states that have or may yet legalize nonmedical cannabis use. Youth from New York State may not be representative of youth in nonlegal states, given New York’s history of liberal cannabis policy, and indeed recent legalization. For the present study, RIGS was advantageous because it had many design features in common with the other samples. Other limitations include the smaller sample size in comparison to population-based cross-sectional studies and threats to internal validity inherent in pre-post designs. These limitations are balanced by important strengths, including the integration of data from 3 intensive studies; the use of longitudinal data with assessments both before and after legalization; and the separation of variance in cannabis use due to age, birth cohort, and legalization.

CONCLUSIONS

Rates of adolescent cannabis use may be holding steady following nonmedical cannabis legalization for adults, but ongoing surveillance is recommended. Future studies should examine potential differences in the impact of legalization across demographic groups. Given the effects of legalization on increased cannabis use by parents,8 future studies should consider whether children of parents who use cannabis are more susceptible to legalization effects than children of parents who abstain.

ACKNOWLEDGMENTS

We gratefully acknowledge the generosity of the participants in our studies. We also thank Sally Schwader and Tanya Williams for editorial assistance. Points of view reflect those of the authors and not the funding agency. This study was supported by funding from the National Institute on Drug Abuse [Oregon Youth Study-Three Generational Study (OYS-3GS) R01 DA015485 awarded to Drs. Deborah Capaldi and David Kerr, Rochester Intergenerational Study (RIGS) R01DA020195 awarded to Dr. Kimberly Henry; Seattle Social Development Project-The Intergenerational Study (SSDP-TIP) R01DA023089 awarded to Dr. Jennifer Bailey]. The funding agency had no role in the design of the study, data collection or analysis, interpretation of results, or the decision to submit this manuscript for publication. No financial disclosures were reported by the authors of this paper.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

CRediT statement:

Jennifer A. Bailey – Data curation, funding acquisition, methodology, conceptualization, project administration (TIP study); writing – original draft.

Stacey S. Tiberio – Formal analysis, methodology, conceptualization, visualization, writing – original draft.

David C.R. Kerr – Funding acquisition, methodology, conceptualization, project administration (3GS study); writing – review & editing.

Marina Epstein – Project administration (TIP study); methodology, conceptualization, writing – review & editing.

Kimberly L. Henry – Data curation, funding acquisition, methodology, conceptualization, project administration (RIGS study); writing – review & editing.

Deborah M. Capaldi – Funding acquisition, methodology, conceptualization, project administration (3GS study); writing – review & editing.

REFERENCES

  • 1.Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance-abuse prevention. Psychol Bull. 1992;112(1):64–105. 10.1037/0033-2909.112.1.64. [DOI] [PubMed] [Google Scholar]
  • 2.Blest-Hopley G, O’Neill A, Wilson R, Giampietro V, Bhattacharyya S. Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use. Psychopharmacology. 2021;238(5):1315–1331. 10.1007/s00213-019-05407-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Volkow ND, Swanson J, Evins E, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry. 2016;73(3):292–297. 10.1001/jamapsychiatry.2015.3278. [DOI] [PubMed] [Google Scholar]
  • 4.Guttmannova K, Kosterman R, White HR, et al. The association between regular marijuana use and adult mental health outcomes. Drug Alcohol Depend. 2017;179:109–116. 10.1016/j.drugalcdep.2017.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cerda M, Mauro C, Hamilton A, et al. Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016. JAMA Psychiatry. 2020;77(2):165–171. 10.1001/jamapsychiatry.2019.3254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hammond D, Goodman SH, Wadsworth E, et al. Evaluating the impacts of cannabis legalization: the International Cannabis Policy Study. Int J Drug Pol. 2020;77:102698. 10.1016/j.drugpo.2020.102698. [DOI] [PubMed] [Google Scholar]
  • 7.Borodovsky JT, Lee DC, Crosier BS, et al. U.S. cannabis legalization and use of vaping and edible products among youth. Drug Alcohol Depend. 2017;177:299–306. 10.1016/j.drugalcdep.2017.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Epstein M, Bailey JA, Kosterman R, Furlong M, Hill KG. Evaluating the effect of retail marijuana legalization on parent marijuana use frequency and norms in U.S. states with retail marijuana legalization. Addict Behav. 2020;111:106564. 10.1016/j.addbeh.2020.106564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hall W. Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes. Int J Drug Policy. 2017;42:57–62. 10.1016/j.drugpo.2016.10.021. [DOI] [PubMed] [Google Scholar]
  • 10.Pacula RL. Examining the impact of marijuana legalization on marijuana consumption: Insights from the economics literature. Santa Monica, CA: Rand; 2010. 10.7249/WR770. [DOI] [Google Scholar]
  • 11.Coley RL, Hawkins SS, Ghiani M, Kruzik C, Baum CF. A quasi-experimental evaluation of marijuana policies and youth marijuana use. Am J Drug Alcohol Abuse. 2019;45(3):292–303. 10.1080/00952990.2018.1559847. [DOI] [PubMed] [Google Scholar]
  • 12.Zuckermann AME, Battista KV, Belanger RE, et al. Trends in youth cannabis use across cannabis legalization: data from the COMPASS prospective cohort study. Prev Med Rep. 2021;22:101351. 10.1016/j.pmedr.2021.101351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rotermann M. What has changed since cannabis was legalized? Health Rep. 2020;31(2):11–20. 10.25318/82-003-x202000200002-eng. [DOI] [PubMed] [Google Scholar]
  • 14.Paschall MJ, Garcia-Ramirez G, Grube JW. Recreational marijuana legalization and use among California adolescents: findings from a statewide survey. J Stud Alcohol Drugs. 2021;82(1):103–111. 10.15288/jsad.2021.82.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dilley JA, Richardson SM, Kilmer B, et al. Prevalence of cannabis use in youths after legalization in Washington State. JAMA Pediatr. 2019;173(2):192–193. 10.1001/jamapediatrics.2018.4458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston, MA: Houghton, Mifflin and Company; 2002. [Google Scholar]
  • 17.Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45(6):644–663. 10.1080/00952990.2019.1669626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rusby JC, Westling E, Crowley R, Light JM. Legalization of recreational marijuana and community sales policy in Oregon: impact on adolescent willingness and intent to use, parent use, and adolescent use. Psychol Addict Behav. 2018;32(1):84–92. 10.1037/adb0000327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bailey JA, Epstein M, Roscoe JN, et al. Marijuana legalization and youth marijuana, alcohol, and cigarette use and norms. Am J Prev Med. 2020;59(3):309–316. 10.1016/j.amepre.2020.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Henry KL, Agbeke DV, Tiberio SS, et al. Does parents’ age at first birth moderate intergenerational continuity in early-onset cannabis use? J Stud Alcohol Drugs. 2021;82(4):470–475. 10.15288/jsad.2021.82.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Substance Abuse and Mental Health Services Administration. (2020). 2018–2019 National Survey on Drug Use and Health: Model-Based Prevalence Estimates (50 States and the District of Columbia). https://www.samhsa.gov/data/report/2018-2019-nsduh-state-prevalence-estimates. Accessed December 29, 2021.
  • 22.Substance Abuse and Mental Health Administration. National and State-level Marijuana Trends From 2002–2014. https://www.samhsa.gov/data/nsduh/national-state-level-marijuana-trends. Accessed September 22, 2021.
  • 23.Kilmer B. How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps. Am J Drug Alcohol Abuse. 2019;45(6):664–672. 10.1080/00952990.2019.1611841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hall W, Lynskey M. Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. Lancet Psychiatry. 2016;3(9):900–906. 10.1016/S2215-0366(16)30071-2. [DOI] [PubMed] [Google Scholar]
  • 25.Bae H, Kerr DCR. Marijuana use trends among college students in states with and without legalization of recreational use: initial and longer-term changes from 2008 to 2018. Addiction. 2020;115(6):1115–1124. 10.1111/add.14939. [DOI] [PubMed] [Google Scholar]

RESOURCES